|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100046538 |
|
最近更新日期: Date of Last Refreshed on: |
2021-12-27 21:54:23 |
|
注册时间: Date of Registration: |
2021-05-21 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
请与我们联系上传伦理批件。 胎儿生长受限的新生儿长期临床队列研究 |
|
Public title: |
Long-term clinical cohort study of neonates with fetal growth restriction |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
胎儿生长受限的新生儿长期临床队列研究 |
|
Scientific title: |
Long-term clinical cohort study of neonates with fetal growth restriction |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
罗晓芳 |
研究负责人: |
漆洪波 |
|
Applicant: |
Luo Xiaofang |
Study leader: |
Qi Hongbo |
|
申请注册联系人电话: Applicant telephone: |
+86 23 89011411 |
研究负责人电话: Study leader's telephone: |
+86 23 89011411 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zhenqianwei@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zhenqianwei@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
重庆市渝中区袁家岗友谊路1号 |
研究负责人通讯地址: |
重庆市渝中区袁家岗友谊路1号 |
|
Applicant address: |
1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing |
Study leader's address: |
1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
重庆医科大学附属第一医院 |
||
|
Applicant's institution: |
The First Affiliated Hospital of Chongqing Medical University |
||
|
研究负责人所在单位: |
重庆医科大学附属第一医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of Chongqing Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2020-599 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
重庆医科大学附属第一医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the First Affiliated Hospital of Chongqing Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-10-14 00:00:00 |
||
|
伦理委员会联系人: |
许平 |
||
|
Contact Name of the ethic committee: |
Xu Ping |
||
|
伦理委员会联系地址: |
重庆市渝中区袁家岗友谊路1号 |
||
|
Contact Address of the ethic committee: |
1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
重庆医科大学附属第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Affiliated Hospital of Chongqing Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
重庆市渝中区袁家岗友谊路1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
重庆医科大学附属第一医院母胎医学实验室 |
||||||||||||||||||||||
|
Source(s) of funding: |
Maternal and Fetal Medicine Laboratory of the First Affiliated Hospital of Chongqing Medical University |
||||||||||||||||||||||
|
Target disease: |
Fetal growth restriction |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
在组建无明显诱因FGR的前瞻性研究队列的基础上,建立双亲与子代的临床生物样本库,收集孕期直至幼儿期研究对象各阶段临床资料,综合评估子代各系统发育水平;进行长期纵向随访研究,探究FGR与双亲行为学关联,以及对子代预后的长期影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
On the basis of establishing a prospective research cohort with no obvious cause of FGR, establish a clinical biological sample bank of parents and offspring, collect clinical data of the study subjects from pregnancy to early childhood, comprehensively evaluate the phylogeny level of offspring; carry out long-term longitudinal Follow-up studies to explore the relationship between FGR and parental behavior and its long-term impact on the prognosis of offspring. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.单胎妊娠,末次月经明确,平常月经规律,子宫形态正常; |
||||||||||||||||||||||
|
Inclusion criteria |
1.Singleton pregnancy, clear last menstruation, regular menstruation, and normal uterine shape; |
||||||||||||||||||||||
|
排除标准: |
遗传性疾病和染色体异常:13-三体综合征,18-三体综合征,腹裂等。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Inherited diseases and chromosomal abnormalities: 13-trisomy syndrome, 18-trisomy syndrome, gastroschisis, etc.. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-06-01 00:00:00至 To 2026-06-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2021-06-01 00:00:00 至 To 2026-06-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
不适用 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
N/A |
|
Blinding: |
N/A |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
妊娠大数据网络平台 http://172.16.143.226/manager/logout。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Pregnancy big data network platform http://172.16.143.226/manager/logout. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集使用病例记录表,数据的管理、归纳、分析和调用采用电子采集和管理系统。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case record forms are used for data collection, and electronic collection and management systems are used for data management, summarization, analysis and transfer. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |